Histamine in the brain: Beyond sleep and memory

Biochemical Pharmacology

Volumn 73, Issue 8, 2007, Pages 1113-1122

  Passani, Maria Beatrice ^a   Giannoni, Patrizia ^a   Bucherelli, Corrado ^b   Baldi, Elisabetta ^b   Blandina, Patrizio ^a  

^a Dipartimento di Farmacologia Preclinica e Clinica   (Italy)

^b Dipartimento di Fisiologia   (Italy)

Author keywords

Acetylcholine; Endocannabinoids; Fear conditioning; Feeding; Hypothalamus; Microdialysis

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; ACETYLCHOLINE; ANANDAMIDE; CIPROXIFAN; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; ENDOCANNABINOID; HISTAMINE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; NEUROTRANSMITTER; RIMONABANT; SCOPOLAMINE; THIOPERAMIDE;

ANXIETY; ARTICLE; BRAIN; CENTRAL NERVOUS SYSTEM; COGNITION; CONDITIONING; FEEDING; HUMAN; HYPOTHALAMUS; LOCOMOTION; MEMORY; MICRODIALYSIS; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; SLEEP; WAKEFULNESS;

EID: 33947116780     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.12.002     Document Type: Note

References (90)

1. Panula P., Yang H.Y., and Costa E. Histamine-containing neurons in the rat hypothalamus. Proc Natl Acad Sci 81 (1984) 2572-2576
2. Watanabe T., Taguchi Y., Hayashi H., Tanaka J., Shiosaka S., Tohyama M., et al. Evidence for the presence of a histaminergic neuron system in the rat brain: an immunohistochemical analysis. Neurosci Lett 39 (1983) 249-254
3. Lin J.S., Sakai K., and Jouvet M. Evidence for histaminergic arousal mechanisms in the hypothalamus of cat. Neuropharmacology 27 (1988) 111-122
4. Weiler H.T., Hasenöhrl R.U., Landeghem A.A.L.V., Landeghem M.V., Brankack J., Huston J.P., et al. Differential modulation of hippocampal signal transfer by tuberomammillary nucleus stimulation in freely moving rats dependent on behavioral state. Synapse 28 (1998) 294-301
5. Parmentier R., Ohtsu H., Djebarra-Hannas Z., Valtx J.-L., Watanabe T., and Lin J.-S. Anatomical, physiological and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci 22 (2002) 7695-7711
6. Parmentier R, Anaclet C, Watanabe T, Lin J-S. Characteristics of cortical EEG and sleep-wake cycle in histamine H1-receptor knock out mice. Delphi: European Histamine Research Society; 2006 [Ed. Athens MSotUo].
7. Saper C., Chou T., and Scammell T. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 24 (2001) 726-731
8. Jones B.E. From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci 26 (2005) 578-586
9. Lin J., Sakai K., and Jouvet M. Hypothalamo-preoptic histaminergic projections in sleep-wake control in the cat. Eur J Neurosci 6 (1994) 618-625
10. Lin J.S., Hou Y., Sakai K., and Jouvet M. Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. J Neurosci 16 (1996) 1523-2137
11. Cecchi M., Passani M.B., Bacciottini L., Mannaioni P.F., and Blandina P. Cortical acetylcholine release elicited by stimulation of histamine H1 receptors in the nucleus basalis magnocellularis: a dual probe microdialysis study in the freely moving rat. Eur J Neurosci 13 (2001) 68-78
12. Aston-Jones G., and Bloom F.E. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1 (1981) 876-886
13. Sakai K., Mansari M.E., Lin J., Zhang J., and Mercier G.V. The posterior hypothalamus in the regulation of wakefulness and paradoxical sleep. In: Mancia M. (Ed). The diencephalon and sleep (1990), Raven Press, New York 171-198
14. Wu M.F., Gulyani S.A., Yau E., Mignot E., Phan B., and Siegel J.M. Locus coeruleus neurons: cessation of activity during cataplexy. Neuroscience 91 (1999) 1389-1399
15. Wu M.F., John J., Boehmer L.N., Yau D., Nguyen G.B., and Siegel J.M. Activity of dorsal raphe cells across the sleep-waking cycle and during cataplexy in narcoleptic dogs. J Physiol 554 (2004) 202-215
16. John J., Wu M.F., Boehmer L.N., and Siegel J.M. Cataplexy-active neurons in the hypothalamus: implications for the role of histamine in sleep and waking behavior. Neuron 42 (2004) 619-634
17. Abe H., Honma S., Ohtsu H., and Honma K. Circadian rhythms in behavior and clock gene expressions in the brain of mice lacking histidine decarboxylase. Brain Res Mol Brain Res 124 (2004) 178-187
18. Selbach O., and Haas H.L. Hypocretins: the timing of sleep and waking. Chronobiol Int 23 (2006) 63-70
19. Eriksson K., Sergeeva O., Brown R., and Haas H. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 21 (2001) 9273-9279
20. Huang Z.-L., Qu W.-M., Li W.-D., Mochizuki T., Eguchi N., Watanabe T., et al. Arousal effect of orexin A depends on activation of the histaminergic system. Proc Natl Acad Sci 98 (2001) 9965-9970
21. Nishino S., Fujiki N., Ripley B., Sakurai E., Kato M., Watanabe T., et al. Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs. Neurosci Lett 313 (2001) 125-128
22. Kanbayashi T., Yano T., Ishiguro H., Kawanishi K., Chiba S., Aizawa R., et al. Hypocretin-1 (orexin-A) levels in human lumbar CSF in different age groups: infants to elderly persons. Sleep 25 (2002) 337-339
23. Blandina P., Efoudebe M., Cenni G., Mannaioni P.F., and Passani M.B. Acetylcholine, histamine and cognition: two sides of the same coin. Learn Mem 11 1 (2004) 1-8
24. Passani M., and Blandina P. The neuronal histaminergic system in cognition. Curr Med Chem 4 (2004) 17-26
25. Vazdarjanova A., and McGaugh J.L. Basolateral amygdala is involved in modulating consolidation of memory for classical conditioning. J Neurosci 19 (1999) 6615-6622
26. 3 receptor-mediated impairment of contextual fear conditioning, and in-vivo inhibition of cholinergic transmission in the rat basolateral amygdala. Eur J Neurosci 14 (2001) 1522-1532
27. Cangioli I., Baldi E., Mannaioni P.F., Bucherelli C., Blandina P., and Passani M.B. Activation of histaminergic H3 receptors in the rat basolateral amygdala improves expression of fear memory and enhances acetylcholine release. Eur J Neurosci 16 (2002) 521-528
28. Fox G.B., Esbenshade T.A., Pan J.B., Radek R.J., Krueger K.M., Yao B.B., et al. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist. J Pharmacol Exp Ther 313 (2005) 176-190
29. Bacciottini L., Passani M., Giovannelli L., Cangioli I., Mannaioni P., Schunack W., et al. Endogenous histamine in the medial septum-diagonal band complex increases the release of acetylcholine from the hippocampus: a dual-probe microdialysis study in the freely moving animal. Eur J Neurosci 15 (2002) 1669-1680
30. Giovannini M., Efoudebe M., Passani M., Baldi E., Bucherelli C., Giachi F., et al. Improvement in fear memory by histamine elicited erk2 activation in hippocampal CA3 cells. J Neurosci 23 (2003) 9016-9023
31. McGaugh J.L., Cahill L., and Roozendaal B. Involvement of the amygdala in memory storage: Interaction with other brain systems. Proc Natl Acad Sci 93 (1996) 13508-13514
32. Freund T.F., Katona I., and Piomelli D. Role of endogenous cannabinoids in synaptic signalling. Physiol Rev 83 (2003) 1017-1066
33. Azad S.C., Monory K., Marsicano G., Cravatt B.F., Lutz B., Zieglgansberger W., et al. Circuitry for associative plasticity in the amygdala involves endocannabinoids signaling. J Neurosci 24 (2004) 9953-9961
34. Marsicano G., Wotjak C.T., Azad S., Bisogno T., Rammes G., Cascio M.G., et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 418 (2002) 530-534
35. Bucherelli C., Baldi E., Mariottini C., Passani M.B., and Blandina P. Aversive memory reactivation engages in the amygdala only some neurotransmitters involved in consolidation. Learn Mem 13 (2006) 426-430
36. Nader K., Schafe G.E., and LeDoux J.E. Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature 406 (2000) 722-726
37. Alberini C.M. Mechanisms of memory stabilization: are consolidation and reconsolidation similar or distinct processes?. Trends Neurosci 28 (2005) 51-56
38. Vianna M., Szapiro G., McGaugh J., Medina J., and Izquierdo I. Retrieval of memory for fear-motivated training initiates extinction requiring protein synthesis in the rat hippocampus. Proc Natl Acad Sci 98 (2001) 12251-12254
39. Lattal K., and Abel T. Behavioral impairments caused by injections of the protein synthesis inhibitor anisomycin after contextual retrieval reverse with time. Proc Natl Acad Sci 101 (2004) 4667-4672
40. Power A.E., Berlau D.J., McGaugh J.L., and Steward O. Anisomycin infused into the hippocampus fails to block "reconsolidation" but impairs extinction: The role of re-exposure duration. Learn Mem 13 (2006) 27-34
41. Lee J.L., Ciano P.D., Thomas K.L., and Everitt B.J. Disrupting reconsolidation of drug memories reduces cocaine-seeking behavior. Neuron 47 (2005) 795-801
42. Liao C., Zheng J., David L.S., and Nicholson R.A. Inhibition of voltage-sensitive sodium channels by the cannabinoid 1 receptor antagonist AM 251 in mammalian brain. Pharmacol Toxicol 94 (2004) 73-78
43. Cahill L., and McGaugh J. A novel demonstration of enhanced memory associated with emotional arousal. Conscious Cogn 4 (1995) 410-421
44. Cenni G., Blandina P., Mackie K., Nosi D., Formigli L., Giannoni P., et al. Differential effect of cannabinoid agonists and endocannabinoids on histamine release from distinct regions of the rat brain. Eur J Neurosci 24 (2006) 1633-1644
45. Solinas M., Panlilio L.V., Tanda G., Makriyannis A., Matthews S.A., and Goldberg S.R. Cannabinoid agonists but not inhibitors of endogenous cannabinoid transport or metabolism enhance the reinforcing efficacy of heroin in rats. Neuropsychopharmacology 30 (2005) 2046-2057
46. Gaetani S., Cuomo V., and Piomelli D. Anandamide hydrolysis: a new target for anti-anxiety drugs?. Trends Mol Med 9 (2003) 474-478
47. Russ M.J., and Ackerman S.H. Antidepressants and weight gain. Appetite 10 (1988) 103-117
48. Toftegaard C.L., Knigge U., Kjaer A., and Warberg J. The role of hypothalamic histamine in leptin-induced suppression of short-term food intake in fasted rats. Regul Pept 111 (2003) 83-90
49. Tuomisto L., Yamatodani A., Jokkonen J., Sainio E., and Airaksinen M. Inhibition of brain histamine synthesis increases food intake and inhibits vasopressin response to salt loading in rats. Methods Find Exp Clin Pharmacol 16 (1994) 355-359
50. Fukagawa K. Neuronal histamine modulates feeding behavior through H1-receptor in rat hypothalamus. Am J Physiol 256 (1989) R605-R611
51. Okuma K., Sakata T., Fukagawa K., et al. Neuronal histamine in the hypothalamus suppresses food intake in rats. Brain Res 628 (1994) 235-242
52. Hillebrand J., Wied D., and Adan R. Neuropeptides, food intake and body weight regulation: a hypothalamic focus. Peptides 23 (2002) 2283-2306
53. Yoshimatsu H., Itateyama E., Kondou S., Hidaka S., Tajima D., and Kurokawa M. Hypothalamic neuronal histamine as a target of leptin action on feeding behavior in the central nervous system. Diabetes 48 (1999) 1342-1346
54. Itateyama E., Chiba S., Sakata T., and Yoshimatsu H. Hypothalamic neuronal histamine in genetically obese animals: its implication of leptin action in the brain. Exp Biol Med 228 (2003) 1132-1137
55. Malmlöf K., Zaragoza F., Golozoubova V., Refsgaard H.H., Cremers T., Raun K., et al. Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight. Int J Obes 29 (2005) 1402-1412
56. Esbenshade T, Hancock A, Bitner R, Krueger K, Otte S, Nikkel A, Fey T, Bush E, Dickinson R, Shapiro R, Knourek-Segel V, Droz B, Brune M, Jacobson P, Cowart M. Distinctions and contradistinctions between antiobesity histamine H(3) receptor (H (3)R) antagonists compared to cognition-enhancing H(3) receptor antagonists. Inflamm Res 2006; Epub ahead of print.
57. Yoshimoto R., Miyamoto Y., Shimamura K., Ishihara A., Takahashi K., Kotani H., et al. Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus. Proc Nat Acad Sci 103 (2006) 13866-13871
58. Valdés J., Fari{dotless}as P., Ocampo-Garce A., Cortes N., Seron-Ferré M., and Torrealba F. Arousal and differential Fos expression in histaminergic neurons of the ascending arousal system during a feeding-related motivated behaviour. Eur J Neurosci 21 (2005) 1931-1942
59. Pfaff D., Frohlich J., and Morgan M. Hormonal and genetic influences on arousal-sexual and otherwise. Trends Neurosci 25 (2002) 45-50
60. Meynard M.M., Valdes J.L., Recabarren M., Seron-Ferre M., and Torrealba F. Specific activation of histaminergic neurons during daily feeding anticipatory behavior in rats. Behav Brain Res 158 (2005) 311-319
61. Recabarren M., Valdés J., Farías P., Serón-Ferré M., and Torrealba F. Differential effects of infralimbic cortical lesions on temperature and locomotor activity responses to feeding in rats. Neuroscience 134 (2005) 1413-1422
62. Hok V., Save E., Lenck-Santini P., and Poucet B. Coding for spatial goals in the prelimbic/infralimbic area of the rat frontal cortex. Proc Natl Acad Sci 102 (2005) 4602-4607
63. Valdés J., Maldonado P., Recabarren M., Fuentes R., and Torrealba F. The infralimbic cortical area commands the behavioral and vegetative arousal during appetitive behavior in the rat. Eur J Neurosci 23 (2006) 1352-1364
64. Panula P., Pirvola U., Auvinen S., and Airaksinen M. Histamine-immunoreactive nerve fibers in the rat brain. Neuroscience 28 (1989) 585-610
65. Galosi R., Lenard L., Knoche A., Haas H., Huston J., and Schwarting R. Dopaminergic effects of histamine administration in the nucleus accumbens and the impact of H1-receptor blockade. Neuropharmacology 40 (2001) 624-633
66. Wagner U., Segura-Torres P., Weiler T., and Huston J. The tuberomammillary nucleus region as a reinforcement inhibiting substrate: facilitation of ipsihypothalamic self-stimulation by unilateral ibotenic acid lesions. Brain Res 613 (1993) 269-274
67. Hasenöhrl R., Kuhlen A., Frisch C., Galosi R., Brandao M., and Huston H. Comparison of intra-accumbens injection of histamine with histamine H1-receptor antagonist chlorpheniramine in effects on reinforcement and memory parameters. Behav Brain Res 124 (2001) 203-211
68. Matias I., Bisogno T., and Marzo V.D. Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake. Int J Obest Suppl 1 (2006) S7-S12
69. Berry E.M., and Mechoulam R. Tetrahydrocannabinol and endocannabinoids in feeding and appetite. Pharmacol Ther 95 (2002) 185-190
70. Kirkham T.C., Williams C.M., Fezza F., and Marzo V.D. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136 (2002) 550-557
71. Jamshidi N., and Taylor D. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol 134 (2001) 1151-1154
72. Morimoto T., Yamamoto Y., Mobarakeh I.J., Yanai K., Watanabe T., and Yamatodani A. Involvement of the histaminergic system in leptin-induced suppression of food intake. Physiol Behav 67 (1999) 679-683
73. DiMarzo V., Goparaju S., Wang L., Liu J., Batkai S., Jarai Z., et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410 (2001) 822-825
74. Sakata T., Fukagawa K., Ookuma K., Fujimoto K., Yoshimatsu H., Yamatodani A., et al. Hypothalamic neuronal histamine modulates ad libitum feeding by rats. Brain Res 537 (1990) 303-306
75. Angeles-Castellanos M., Mendoza J., Diaz-Munoz M., and Escobar C. Food entrainment modifies the c-Fos expression pattern in brain stem nuclei of rats. Am J Physiol Regul Integr Comp Physiol 288 (2005) R678-R684
76. Schneider M., and Koch M. The cannabinoid agonist WIN 55,212-2 reduces sensorimotor gating and recognition memory in rats. Behav Pharmacol 13 (2002) 29-37
77. Orsetti M., Ferretti C., Gamalero R., and Ghi P. Histamine H3-receptor blockade in the rat nucleus basalis magnocellularis improves place recognition memory. Psychopharmacology 159 (2002) 133-137
78. Malmberg-Aiello P., Ipponi A., Blandina P., Bartolini L., and Schunack W. Pro-cognitive effect of a selective H1 receptor agonist, 2-(3-trifluoromethylphenyl)histamine, in the rat object recognition test. Inflam Res 52 (2003) S33-S34
79. Westerink B.H., Cremers T.I., Vries J.B.D., Liefers H., Tran N., and Boer P.D. Evidence for activation of histamine H3 autoreceptors during handling stress in the prefrontal cortex of the rat. Synapse 15 (2002) 238-243
80. Brown L. Somatotopic organization in the rat striatum: evidence for a combinatorial map. Proc Nat Acad Sci 89 (1992) 7403-7407
81. Hyman S.E., and Malenka R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nature Rev Neurosci 2 (2001) 695-703
82. Chiavegatto S., Nasello A.G., and Bernardi M.M. Histamine and spontaneous motor activity: biphasic changes, receptors involved and participation of the striatal dopamine system. Life Sci 62 (1998) 1875-1888
83. McLaughlin P.J., Lu D., Winston K.M., Thakur G., Swezey L.A., Makriyannis A., et al. Behavioral effects of the novel cannabinoid full agonist AM 411. Pharmacol Biochem Behav 81 (2005) 78-88
84. Sanudo-Pena M.C., Tsou K., and Walker J.M. Motor actions of cannabinoids in the basal ganglia output nuclei. Life Sci 65 (1999) 703-713
85. Huang C.-C., Lo S.-W., and Hsu K.-S. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. J Physiol 532.3 (2001) 731-748
86. Köfalvi A., Rodrigues R.J., Ledent C., Mackie K., Vizi E.S., Cunha R.A., et al. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. J Neurosci 25 (2005) 2874-2884
87. Miklos I., and Kovacs K. Functional heterogeneity of the responses of histaminergic neuron subpopulations to various stress challenges. Eur J Neurosci 18 (2003) 3069-3079
88. Sergeeva O.A., Eriksson K.S., Sharonova I.N., Vorobjev V.S., and Haas H.L. GABA(A) receptor heterogeneity in histaminergic neurons. Eur J Neurosci 16 (2002) 1472-1482
89. Pillot C., Heron A., Cochois V., Tardivel-Lacombe J., Ligneau X., Schwartz J.-C., et al. A detailed mapping of the histamine H3 receptor and its gene transcript in rat brain. Neuroscience 114 (2002) 173-193
90. Giannoni P., Cenni G., Passani M., Mannaioni P., Medhurst A., and Blandina P. Different responses to GABAA or H3 antagonists suggest the existence of distinct subpopulations among histaminergic neurons. Proceedings of the XXXV European histamine research society (2006) 52 [Ed. Athens MSotUo]